跳至主要内容
临床试验/IRCT20171118037516N1
IRCT20171118037516N1招募中3 期

Evaluation the effectiveness of a mixture-syrup based on pomegranate and spearmint (Vomigramint), compared with placebo, on Chemotherapy induced nausea and vomiting (CINV) in breast cancer

Sari University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • More than 18 years-old aging
  • Documentary report for Breast cancer
  • At least one session of chemotherapy is done prior to intervention
  • Taking similar and one-day chemotherapy regimen
  • At least two sessions of chemotherapy is proceeding
  • History of any level of CINV (qualitative or quantative), despite taking routine anti-emetic drugs.

排除标准

  • Total or upper abdomen radiotherapy, accompanying with chemotherapy simultaneously
  • Consumption therapeutic dosage of anti-coagulant agents
  • History of coagulopathic disorders
  • Taking anti- emetic drugs or methods, except those permitted drugs in this study
  • History of hypersensitivity to pomegranate or spearmint
  • Pomegranate or spearmint consumption during one week prior to intervention
  • Suffering from other cancers or metastatic breast cancer simultaneously
  • Having other problems or diseases causing nausea( e.g. Hypertension, Liver or Renal failure, Diabetes mellitous , Constipation )

研究者

发起方
Sari University of Medical Sciences

相似试验